ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 139021 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 139021; 2) Community: the network communities that were significantly associated with the response to NSC 139021; 3) Molecule: the relationships between components within communities and NSC 139021; 4) MDR: the compounds that were significantly associated with the NSC 139021.

NSC Compound Enrichment Correlation
NSC 655105 Cycloshikonin 0.0135712240673827 0.50112907
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.0135712240673827 0.60867642
NSC 664951 Null 0.0135712240673827 0.50785781
NSC 668300 Null 0.0135712240673827 0.46509494
NSC 672055 Null 0.0135712240673827 0.47521952
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.0135712240673827 0.53804995
NSC 687011 stereoisomer of 672120 (MW=262) 0.0135712240673827 0.60085756
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.0135712240673827 0.56525157
NSC 710342 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyophenyl)-5,7-dihydroxy-3,6,8-tris(3-methyl-2-butenyl)- (9CI) 0.0135712240673827 0.48489811
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0135712240673827 0.46377009
Total:115  Current:41    [First] [Prev] [Next] [Last]